Latest papers

[Full-term delivery following intracytoplasmic sperm injection in a case of male hypogonadotropic hypogonadism after 8-year treatment with HCG and HMG]

Prospective, randomized, comparative study of leuprorelin + human menopausal gonadotropins versus ganirelix + recombinant follicle-stimulating hormone in oocyte donors and pregnancy rates among the corresponding recipients.

Efficacy and safety of HMG versus r-FSH.

[Efficacy of guided ovarian hyperstimulation in patients with mild type endometriosis]

Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IVF or ICSI treatment: a systematic review and meta-analysis.

The variation of serum cortisol during ovarian stimulation for in vitro fertilization.

Efficacy and safety of human menopausal gonadotrophins versus recombinant FSH: a meta-analysis.

Early cleavage does not predict treatment outcome following the use of GnRH antagonists in women older than 35.

Assessment of gonadotropin therapy in male hypogonadotropic hypogonadism.

An economic evaluation of highly purified HMG and recombinant FSH based on a large randomized trial.

Retinopathy of prematurity.

Morphometric study of GnRH analog/HMG/HCG effects on ultrastructure of human endometrial epithelium in early and mid-luteal phase.

Natural cycle IVF: a question of semantics?

Influence of ovarian stimulation with HP-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVF.

Minimal ovarian stimulation with clomiphene citrate: a large-scale retrospective study.

Adding human menopausal gonadotrophin to antagonist protocols - is there a benefit?

Application of GnRH antagonist in combination with clomiphene citrate and hMG for patients with exaggerated ovarian response in previous IVF/ICSI cycles.

Subtle progesterone rise in the single-dose gonadotropin-releasing hormone antagonist (cetrorelix) stimulation protocol in patients undergoing in vitro fertilization or intracytoplasmic sperm injection cycles.

Comparing highly purified hMG and rFSH in patients undergoing IVF.

Human menopausal and pregnant mare serum gonadotrophins in murine superovulation regimens for transgenic applications.